scispace - formally typeset
Book ChapterDOI

Herb Pair Danggui-Baishao: Pharmacological Mechanisms Underlying Primary Dysmenorrhea by Network Pharmacology Approach

TLDR
A network pharmacology-based approach was adopted to provide new insights into the active compounds and therapeutic targets of Danggui-Baishao herb pair for the treatment of primary dysmenorrhea, finding that these targets were mainly involved in Steroid hormone biosynthesis, Arachidonic acid metabolism, serotonergic synapse and response to oxidative stress.
Abstract
Epidemiological studies have shown that primary dysmenorrhea is the most common disease in gynecology, and its incidence rate is between 20% and 90%, which is a common cause of affecting women’s normal work and quality of life. Its high incidence rate, wide spread and economic losses and social harm have caused widespread concern worldwide. The present work adopted a network pharmacology-based approach to provide new insights into the active compounds and therapeutic targets of Danggui-Baishao herb pair for the treatment of primary dysmenorrhea. Fifteen active compounds of the herb pair possessing favorable pharmacokinetic profiles and biological activities were selected, interacting 17 dysmenorrhea-related targets to provide potential synergistic therapeutic actions. Systematic analysis of the constructed networks revealed that these targets such as ABCB1, ESR1, PGR, AKR1C3, PTGS2, CYP2C8, PTGS1 were mainly involved in Steroid hormone biosynthesis, Arachidonic acid metabolism, serotonergic synapse and Ovarian steroidogenesis through steroid metabolic process, steroid hormone mediated signaling pathway, cyclooxygenase pathway, response to estradiol and response to oxidative stress.

read more

References
More filters
Journal ArticleDOI

Discovery of drug mode of action and drug repositioning from transcriptional responses

TL;DR: This work developed an automatic and robust approach that exploits similarity in gene expression profiles following drug treatment, across multiple cell lines and dosages, to predict similarities in drug effect and MoA, and correctly predicted the MoA for nine anticancer compounds and was able to discover an unreported effect for a well-known drug.
Journal ArticleDOI

Primary dysmenorrhea: advances in pathogenesis and management.

TL;DR: Evidence-based data support the efficacy of cyclooxygenase inhibitors, such as ibuprofen, naproxen sodium, and ketoprofen; and estrogen-progestin oral contraceptive pills (OCPs), and the amount of menstrual prostanoids released is reduced, with concomitant reduction in uterine hypercontractility.
Journal ArticleDOI

The Prevalence and Risk Factors of Dysmenorrhea

TL;DR: It is confirmed that dys menorrhea improves with increased age, parity, and use of oral contraceptives and is positively associated with stress and family history of dysmenorrhea.
Journal ArticleDOI

Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea

TL;DR: Among women with primary dysmenorrhoea, NSAIDs were more effective for pain relief than placebo, and there was little evidence of the superiority of any individual NSAID for either pain relief or safety.
Journal ArticleDOI

Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2018

TL;DR: In the present special issue, several original and review articles addressing potential nutritional, pharmacological, and behavioral strategies that could be used to counteract inflammatory process associated with a variety of diseases including obesity, periodontal disease, myocardial infarction, and pneumonia are gathered.
Related Papers (5)